Pharma Equity Group A/S: Financial statements 2019
CVR: 26791413
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Pharma Equity Group A/S (CVR 26791413) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK -14,417,000 compared with DKK -7,713,000 the year before. Equity in the 2019 report amounted to DKK 67,155,000. The solvency ratio was 92.8%.
- Profit/Loss
- DKK -14,417,000
- Equity
- DKK 67,155,000
- Total Assets
- DKK 72,397,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | - | -14.4 mio. | 67.2 mio. | - |
| 2018 | - | - | -7.7 mio. | 77.6 mio. | - |
| 2017 | - | - | -4.1 mio. | 103.3 mio. | - |
| 2016 | - | - | -2 mio. | 96.8 mio. | - |
| 2015 | - | - | -3.7 mio. | 99.5 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of December 9, 2019, AIDER Godkendt Revisionsaktieselskab has stepped down as auditor of Pharma Equity Group A/S.
Pharma Equity Group A/S has published its interim report for the period January 1, 2019 – June 30, 2019.
As of September 30, 2019, Ulrik Feldstedt Hjorth has joined the board of directors of Pharma Equity Group A/S.
As of September 30, 2019, Rolf Gordon Adamson has joined the board of directors of Pharma Equity Group A/S.
As of September 30, 2019, Peer Henning Borg has left the board of directors of Pharma Equity Group A/S.
As of September 30, 2019, Peter Miro Hauge Jensen is registered as adm. dir. of Pharma Equity Group A/S.
As of September 30, 2019, Peer Henning Borg has stepped down as adm. dir. of Pharma Equity Group A/S.
Pharma Equity Group A/S has published its annual report for 2018. The net result was DKK -7,713,000.
As of April 26, 2019, Morten Søndergaard Schwensen has stepped down as auditor of Pharma Equity Group A/S.
About Pharma Equity Group A/S
Pharma Equity Group A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2002. The company is registered under the industry Investering for egen regning. The company was previously named BLUE VISION A/S and GUDME RAASCHOU VISION A/S. The management consists of Christian Henrik Tange. The board consists of Christian Vinding Thomsen (chair), Charlotte Pahl, Lars Rosenkrantz Gundorph and Omar Siraj M Qandeel. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and FINANSMANAGEMENT ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 0. Equity in the 2025 report amounted to DKK 25,472,000.